Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Similar articles for PubMed (Select 23347334)

1.

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.

Naismith GD, Smith LA, Barry SJ, Munro JI, Laird S, Rankin K, Morris AJ, Winter JW, Gaya DR.

Aliment Pharmacol Ther. 2013 Mar;37(6):613-21. doi: 10.1111/apt.12221. Epub 2013 Jan 24.

2.

A simple method for assessing intestinal inflammation in Crohn's disease.

Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I.

Gut. 2000 Oct;47(4):506-13.

3.

A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease.

Naismith GD, Smith LA, Barry SJ, Munro JI, Laird S, Rankin K, Morris AJ, Winter JW, Gaya DR.

J Crohns Colitis. 2014 Sep;8(9):1022-9. doi: 10.1016/j.crohns.2014.01.029. Epub 2014 Feb 22.

PMID:
24566170
4.

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.

Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M.

Gut. 2005 Mar;54(3):364-8.

5.

Faecal calprotectin: a new marker for Crohn's disease?

Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A.

Ann Clin Biochem. 2004 May;41(Pt 3):230-2.

PMID:
15117438
6.

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.

Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.

Dig Liver Dis. 2008 Jul;40(7):547-53. doi: 10.1016/j.dld.2008.01.017. Epub 2008 Mar 20.

PMID:
18358796
7.

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.

Sipponen T, Kärkkäinen P, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M.

Aliment Pharmacol Ther. 2008 Nov 15;28(10):1221-9. doi: 10.1111/j.1365-2036.2008.03835.x. Epub 2008 Aug 26.

8.

Faecal calprotectin in the assessment of Crohn's disease activity.

Gaya DR, Lyon TD, Duncan A, Neilly JB, Han S, Howell J, Liddell C, Stanley AJ, Morris AJ, Mackenzie JF.

QJM. 2005 Jun;98(6):435-41. Epub 2005 May 6.

9.

Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.

Laharie D, Mesli S, El Hajbi F, Chabrun E, Chanteloup E, Capdepont M, Razaire S, de Lédinghen V, Zerbib F.

Aliment Pharmacol Ther. 2011 Aug;34(4):462-9. doi: 10.1111/j.1365-2036.2011.04743.x. Epub 2011 Jun 14.

10.

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.

Lamb CA, Mohiuddin MK, Gicquel J, Neely D, Bergin FG, Hanson JM, Mansfield JC.

Br J Surg. 2009 Jun;96(6):663-74. doi: 10.1002/bjs.6593.

PMID:
19384912
11.

Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.

Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, Karoui S, Zouari B, Boubaker J, Kaabachi N, Filali A.

Eur J Gastroenterol Hepatol. 2010 Mar;22(3):340-5. doi: 10.1097/MEG.0b013e32832bab49.

PMID:
19581809
12.

The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound.

Orlando A, Modesto I, Castiglione F, Scala L, Scimeca D, Rispo A, Teresi S, Mocciaro F, Criscuoli V, Marrone C, Platania P, De Falco T, Maisano S, Nicoli N, Cottone M.

Eur Rev Med Pharmacol Sci. 2006 Jan-Feb;10(1):17-22.

PMID:
16494106
13.

Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.

Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.

Am J Gastroenterol. 2010 Jan;105(1):162-9. doi: 10.1038/ajg.2009.545. Epub 2009 Sep 15.

PMID:
19755969
14.

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Sterpi C, Marchi S, Maltinti G.

Dig Liver Dis. 2003 Sep;35(9):642-7.

PMID:
14563186
15.

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.

Sipponen T, Björkesten CG, Färkkilä M, Nuutinen H, Savilahti E, Kolho KL.

Scand J Gastroenterol. 2010 Mar;45(3):325-31. doi: 10.3109/00365520903483650.

PMID:
20034360
16.

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.

Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.

Dig Liver Dis. 2014 Nov;46(11):974-9. doi: 10.1016/j.dld.2014.07.013. Epub 2014 Aug 2.

PMID:
25096964
17.

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.

Inflamm Bowel Dis. 2012 Dec;18(12):2218-24. doi: 10.1002/ibd.22917. Epub 2012 Feb 16.

PMID:
22344983
18.

Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.

Lasson A, Strid H, Ohman L, Isaksson S, Olsson M, Rydström B, Ung KA, Stotzer PO.

J Crohns Colitis. 2014 Aug;8(8):789-95. doi: 10.1016/j.crohns.2013.12.015. Epub 2014 Jan 11.

PMID:
24418661
19.

Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin.

Makanyanga JC, Pendsé D, Dikaios N, Bloom S, McCartney S, Helbren E, Atkins E, Cuthbertson T, Punwani S, Forbes A, Halligan S, Taylor SA.

Eur Radiol. 2014 Feb;24(2):277-87. doi: 10.1007/s00330-013-3010-z. Epub 2013 Sep 12.

PMID:
24026620
20.

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease.

Sipponen T, Savilahti E, Kärkkäinen P, Kolho KL, Nuutinen H, Turunen U, Färkkilä M.

Inflamm Bowel Dis. 2008 Oct;14(10):1392-8. doi: 10.1002/ibd.20490.

PMID:
18484671
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk